These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Essential concepts of addiction for general nursing practice. Allen K Nurs Clin North Am; 1998 Mar; 33(1):1-13. PubMed ID: 9478902 [TBL] [Abstract][Full Text] [Related]
4. The orbitofrontal cortex, impulsivity, and addiction: probing orbitofrontal dysfunction at the neural, neurochemical, and molecular level. Winstanley CA Ann N Y Acad Sci; 2007 Dec; 1121():639-55. PubMed ID: 17846162 [TBL] [Abstract][Full Text] [Related]
5. Addiction: making the connection between behavioral changes and neuronal plasticity in specific pathways. Wolf ME Mol Interv; 2002 Jun; 2(3):146-57. PubMed ID: 14993375 [No Abstract] [Full Text] [Related]
6. The cocaine epidemic: treatment options for cocaine dependence. Chychula NM; Okore C Nurse Pract; 1990 Aug; 15(8):33-40. PubMed ID: 2204847 [TBL] [Abstract][Full Text] [Related]
7. A role for sensitization in craving and relapse in cocaine addiction. Kalivas PW; Pierce RC; Cornish J; Sorg BA J Psychopharmacol; 1998; 12(1):49-53. PubMed ID: 9584968 [TBL] [Abstract][Full Text] [Related]
8. D1 dopamine receptor: a putative neurochemical and behavioral link to cocaine action. Hummel M; Unterwald EM J Cell Physiol; 2002 Apr; 191(1):17-27. PubMed ID: 11920678 [TBL] [Abstract][Full Text] [Related]
9. A pharmacological classification of drugs of abuse. Nahas GG Bull Narc; 1981; 33(2):1-19. PubMed ID: 6272921 [TBL] [Abstract][Full Text] [Related]
10. [The dopamine transporter: characterization and physiopathologic implications]. Thibaut F; Vaugeois JM; Petit M Encephale; 1995; 21(6):445-51. PubMed ID: 8674469 [TBL] [Abstract][Full Text] [Related]
11. Cocaine addiction as a neurological disorder: implications for treatment. Majewska MD NIDA Res Monogr; 1996; 163():1-26. PubMed ID: 8809851 [TBL] [Abstract][Full Text] [Related]
12. Postanesthesia care of the cocaine abuser. Rogers EJ J Post Anesth Nurs; 1991 Apr; 6(2):102-7. PubMed ID: 1706772 [TBL] [Abstract][Full Text] [Related]
13. The psychogenetically selected Roman high- and low-avoidance rat lines: a model to study the individual vulnerability to drug addiction. Giorgi O; Piras G; Corda MG Neurosci Biobehav Rev; 2007; 31(1):148-63. PubMed ID: 17164110 [TBL] [Abstract][Full Text] [Related]
14. Social determinates of health: focus on substance use and abuse. Malliarakis KD; Lucey P Nurs Econ; 2007; 25(6):368-70, 375. PubMed ID: 18240840 [TBL] [Abstract][Full Text] [Related]
18. ['Pharmacologic interventions in drug addiction': an advisory report from the Health Council of the Netherlands]. Goppel MA; van den Brink W; van Ree JM Ned Tijdschr Geneeskd; 2003 Aug; 147(34):1637-40. PubMed ID: 12966629 [TBL] [Abstract][Full Text] [Related]
19. Drug addictions. Molecular and cellular endpoints. Kreek MJ Ann N Y Acad Sci; 2001 Jun; 937():27-49. PubMed ID: 11458539 [TBL] [Abstract][Full Text] [Related]
20. Overview of substance abuse: implications for the primary care nurse practitioner. Long MC Nurse Pract Forum; 1993 Dec; 4(4):191-8. PubMed ID: 8298337 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]